3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
10
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
4
Breast Neoplasms
3
Neoplasms
2
Vomiting
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcopenia
1
Sarcoglycanopathies
1
Radiation Induced Oral Mucositis
1
Pulmonary Disease, Chronic Obstructive
1
Malnutrition
1
Lung Neoplasms
1
Liver Neoplasms
1
Liver Diseases
1
Hypothermia
1
Hemianopsia
1
Gastrointestinal Neoplasms
1
Frailty
1
Esophageal Neoplasms
1
Colonoscopy
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Oxaliplatin
10
Fluorouracil
6
Irinotecan
5
Docetaxel
5
Capecitabine
5
tislelizumab
4
S 1 (combination)
4
Paclitaxel
4
Endoscopic Mucosal Resection
4
XELOX
3
Levoleucovorin
3
Laparoscopy
3
Folfox protocol
3
sintilimab
2
apatinib
2
Proton Pump Inhibitors
2
Gastroenterostomy
2
Gastrectomy
2
Clarithromycin
2
Chemotherapy, Adjuvant
2
Amoxicillin
2
vactosertib
1
titanium silicide
1
pembrolizumab
1
lenvatinib
1
durvalumab
1
bismuth tripotassium dicitrate
1
anlotinib
1
Trastuzumab
1
Tranexamic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Stomach Neoplasms
×
Standard of Care
×
Clear all
NCT07184047
2026-02-20
TOX-FRAIL
Ankara Etlik City Hospital
Completed
72 enrolled